A61P 25/00
Drugs for disorders of the nervous system
A61P25/00 (Drugs for disorders of the nervous system) appears on 66,566 US grants and 100,607 published applications in this corpus.
Search patents in A61P- Granted patents
- 66,566
- Published applications
- 100,607
- Assignees
- 18,090
- Inventors
- 118,770
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 91 | 0 |
| 1977 | 109 | 0 |
| 1978 | 160 | 0 |
| 1979 | 138 | 0 |
| 1980 | 152 | 0 |
| 1981 | 200 | 0 |
| 1982 | 172 | 0 |
| 1983 | 136 | 0 |
| 1984 | 177 | 0 |
| 1985 | 252 | 0 |
| 1986 | 226 | 0 |
| 1987 | 232 | 0 |
| 1988 | 270 | 0 |
| 1989 | 370 | 0 |
| 1990 | 337 | 0 |
| 1991 | 372 | 0 |
| 1992 | 323 | 0 |
| 1993 | 304 | 0 |
| 1994 | 337 | 0 |
| 1995 | 374 | 0 |
| 1996 | 521 | 0 |
| 1997 | 774 | 0 |
| 1998 | 830 | 0 |
| 1999 | 907 | 0 |
| 2000 | 950 | 0 |
| 2001 | 1183 | 360 |
| 2002 | 1358 | 1964 |
| 2003 | 1326 | 2926 |
| 2004 | 1074 | 3681 |
| 2005 | 1090 | 3679 |
| 2006 | 1549 | 3840 |
| 2007 | 1580 | 4065 |
| 2008 | 1690 | 4778 |
| 2009 | 2031 | 5417 |
| 2010 | 2758 | 6215 |
| 2011 | 2821 | 5739 |
| 2012 | 3337 | 5367 |
| 2013 | 3792 | 4435 |
| 2014 | 3797 | 4487 |
| 2015 | 3455 | 4418 |
| 2016 | 3031 | 4287 |
| 2017 | 3239 | 4030 |
| 2018 | 2804 | 3945 |
| 2019 | 2779 | 4134 |
| 2020 | 2670 | 3808 |
| 2021 | 2345 | 3636 |
| 2022 | 1930 | 3479 |
| 2023 | 1675 | 3494 |
| 2024 | 1719 | 3338 |
| 2025 | 1780 | 3061 |
| 2026 | 1039 | 2024 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- A61P 25/28Drugs for disorders of the nervous system: for treating neurodegenerative disorders of30,340
- A61P 25/14Drugs for disorders of the nervous system: for treating abnormal movements14,897
- A61P 25/04Centrally acting analgesics12,948
- A61P 25/24Antidepressants11,686
- A61P 25/18Antipsychotics, i.e. neuroleptics10,855
- A61P 25/08Antiepileptics7,807
- A61P 25/22Anxiolytics7,707
- A61P 25/02Drugs for disorders of the nervous system: for peripheral neuropathies7,113
Recent patents
- Method of treating and ameliorating depression6 Oct 2026US 12,751,935 B2The United States Government as represented by the Department of Veterans Affairs
- Injectable formulations in a method for treating pain6 Oct 2026US 12,751,943 B2Pelthos Therapeutics Inc.
- Compound for the treatment and prevention of central nervous system disorders6 Oct 2026US 12,751,945 B2Abaxys Therapeutics
- Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybin6 Oct 2026US 12,751,960 B2Compass Pathfinder Limited
- Compositions comprising human milk oligosaccharides for use in a subject to support maturation of sleeping patterns6 Oct 2026US 12,751,962 B2Societe des Produits Nestle S. A.
- Method of addressing alzheimer's disease or non-alzheimer's dementia8 Oct 2026US 2026/0305670 A1G. Nofar Food Agency Ltd.
- Methods of determining glucose hypometabolism-induced energy crisis and treatments thereof8 Oct 2026US 2026/0306018 A1Senovia Biosciences LLC
- Composition and Method for Topical Trans-spinal Delivery of Nucleic Acids and Small Molecules8 Oct 2026US 2026/0306414 A13P Biotechnologies, Inc.
- Composition for removing and inhibiting senescent cells, and uses thereof8 Oct 2026US 2026/0306460 A1Lifeceutix Co., Ltd.
- Compounds for treating hereditary spastic paraplegia8 Oct 2026US 2026/0306465 A1Children's Medical Center Corporation
Most cited
By later US patents
- Humanized immunoglobulins2,884US 5,585,089 AProtein Design Labs, Inc. · 1996
- Humanized immunoglobulins2,259US 5,530,101 AProtein Design Labs, Inc. · 1996
- Humanized immunoglobulins2,030US 5,693,762 AProtein Design Labs, Inc. · 1997
- Modular infusion device and method1,554US 6,749,587 B2Insulet Corporation · 2004
- Humanized immunoglobulins and methods of making the same1,467US 6,180,370 B2Protein Design Labs, Inc. · 2001